Skip to main content

Table 2 Baseline characteristics of randomized participants

From: Corticosteroid injection for shoulder pain: single-blind randomized pilot trial in primary care

Characteristic

Methylprednisolone acetate with lidocaine (n = 19)

Lidocaine (n = 21)

Female, n (%)

11 (58%)

15 (71%)

Age at randomization in years, mean (SD)

61.5 (5.8)

56.0 (11.3)

Ethnic group:

  

  White

19 (100%)

19(90%)

  Bangladesh/Indian

0

2 (10%)

Have major medical history

9 (47%)

9 (43%)

Right/left handed:

  

  Right

18 (95%)

18 (86%)

  Left

1 (5%)

3 (14%)

Which shoulder affected:

  

  Right

13 (68%)

12 (57%)

  Left

6 (32%)

9 (43%)

History of trigger for the shoulder pain

5 (26%)

6 (29%)

Current medication for shoulder problem:

  

  Painkillers

11 (58%)

11 (52%)

  Anti-inflammatory medication

12 (63%)

11 (52%)

  Physiotherapy

3 (16%)

5 (24%)

  Other

  

Shoulder stiffness addition to shoulder pain

9 (47%)

12 (57%)

Arm pain addition to shoulder pain

17 (89%)

19 (90%)

Neck pain addition to shoulder pain

9 (47%)

7 (33%)

Other symptoms addition to shoulder pain

6 (32%)

6 (29%)

Duration of any symptom in this shoulder for this episode (weeks), mean (SD)

15.9 (6.1)

10.7 (5.0)

History of shoulder pain

5 (26%)

6 (29%)

Systolic blood pressure, mmHg

130 (14.4)

133 (22.4)

Diastolic blood pressure, mmHg

80 (11.2)

77 (14.7)

Body temperature in °C, mean (SD)

36.7 (0.43)

36.7 (0.44)

Rotation of the glenohumeral joint compared to other side:

  

  Greater that 50%

17 (89%)

17 (81%)

  Less than 50%

2 (11%)

4 (19%)